BioGX

Biotechnology Research • Hoover, Alabama, United States • 51-100 Employees

Company overview

Headquarters	2450 Valleydale Rd, Birmingham, Alabama 35244, US
Phone number	+12052508055
Website	biogx.com
NAICS	541714
SIC	873
Keywords	Biochemistry, Custom Sample-Ready, Micobiology, Smartcycler Platform
Founded	2007
Employees	51-100
Socials

Key Contact at BioGX

Brad Hart

Director Of Sales And Marketing

BioGX Email Formats

BioGX uses 2 email formats. The most common is {first name}.{last name} (e.g., john.doe@biogx.com), used 56.5% of the time.

Format	Example	Percentage
{first name}.{last name}	john.doe@biogx.com	56.5%
{first initial}.{last name}	j.doe@biogx.com	43.5%

About BioGX

BioGX, Inc. is a global molecular diagnostics company that has been focused on the health and safety of communities all over the world from its inception in 2007, originally developing tests for Water Quality, Food Safety and Pharma Quality Control. The company has since grown into a formidable contender in the molecular diagnostics industry, leading the way for simple yet superior molecular diagnostics testing. Headquartered in Alabama, USA, BioGX’s American footprint allows for the manufacture of custom-designed, platform agnostic Sample-Ready™ reagents for Laboratory Developed Tests (USA only). Using real-time PCR, BioGX makes molecular testing easy for labs with its novel Sample-Ready™ approach to LDTs, which enables a lab to specify its choice of test and receive a high-performance mix of all the necessary reagents, primers and probes, lyophilized and in one tube without the need for refrigeration. The proprietary Sample-Ready™ technology is at the core of the company’s worldwide offerings across clinical, food safety, pharma and water quality testing. Wholly owned subsidiary, BioGX BV, is located in Amsterdam, The Netherlands and boasts a large portfolio of CE-IVD marked tests, spread across a wide variety of infectious diseases ranging from COVID-19, respiratory, sexual health, enteric pathogens, drug resistance, meningitis, transplant, and tropical disease. With our Global Partnership Initiative, we can supply the rest of the world with our products, fast and effectively. All BioGX reagents are fine-tuned to ensure the highest performance in any lab setting, even outer space, where our products are currently used on the International Space Station. Through continuous innovation our team of scientists aim to make RT-PCR as simple, robust and efficient for laboratories all over the world.

BioGX revenue & valuation

Annual revenue	$32,900,000
Revenue per employee	$597,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$105,000,000
Total funding	No funding